AERI
Aerie Pharmaceuticals Inc
Price:  
15.25 
USD
Volume:  
1,206,402.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aerie Relative Valuation

-183.7%
Upside

As of 2024-03-01, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (12.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -183.7%.

The range of the Relative Valuation is (12.23) - (11.38) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.5x - 15.4x 14.4x
Forward P/E multiples 16.5x - 23.6x 20.0x
Fair Price (12.23) - (11.38) (12.76)
Upside -180.2% - -174.6% -183.7%
15.25 USD
Stock Price
(12.76) USD
Fair Price

Aerie Relative Valuation - Historical P/E Data

Date P/E